Renal cyclic 3′,5′-guanosine monophosphate and sodium excretion in Dahl salt-resistant and Dahl salt-sensitive rats:: comparison of the roles of bradykinin and nitric oxide

被引:1
作者
Millatt, LJ [1 ]
Siragy, HM [1 ]
机构
[1] Univ Virginia Hlth Syst, Dept Internal Med, Charlottesville, VA 22908 USA
关键词
kidney; Dahl rat; cGMP; bradykinin; nitric oxide; icatibant; L-NAME; hypertension; sodium; microdialysis;
D O I
10.1097/00004872-200018100-00018
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective The purpose of this study was to determine the relative importance of bradykinin and nitric oxide (NO) in mediating renal responses to altered sodium intake in Dahl salt-resistant (Dahl-SR) and salt-sensitive (Dahl-SS) rats. Design and methods Dahl-SR and Dahl-SS rats consumed a diet containing 0.15% (low) or 4.0% (high) sodium chloride for 10 days. A microdialysis technique was then used to measure renal cortical interstitial fluid (RIF) cyclic 3',5'-guanosine monophosphate (cGMP) production in anesthetized rats, under baseline conditions and during acute cortical infusion of either the bradykinin B-2 receptor antagonist icatibant or the NO synthase inhibitor nitro-L-arginine methyl ester (L-NAME). Urine sodium excretion was monitored simultaneously by ureter cannulation. Results Baseline sodium excretion was similar in the two types of rats, but RIF cGMP was significantly elevated in Dahl-SR compared to Dahl-SS rats on both low and high sodium diets. Icatibant infusion significantly reduced both RIF cGMP and sodium excretion in Dahl-SR rats during low sodium intake, but had no effect in Dahl-SS rats on either diet L-NAME infusion significantly reduced sodium excretion in Dahl-SR and Dahl-SS rats, during both low and high sodium intake. L-NAME infusion caused a significant reduction in RIF cGMP in Dahl-SR and Dahl-SS rats on low sodium diet, but reduced RIF cGMP only in Dahl-SR rats on high sodium diet. Conclusion These data suggest a potential role for cortical bradykinin, but not NO, in mediating the differences in the renal response to low sodium intake between Dahl-SR and Dahl-SS rats. J Hypertens 18:1491-1496 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:1491 / 1496
页数:6
相关论文
共 32 条
[1]   REDUCED URINARY KALLIKREIN ACTIVITY IN RATS DEVELOPING SPONTANEOUS HYPERTENSION [J].
ADER, JL ;
TUAN, TV ;
PRADDAUDE, F .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 252 (06) :F964-F969
[2]   Effect of high salt intake in mutant mice lacking bradykinin-B-2 receptors [J].
Alfie, ME ;
Sigmon, DH ;
Pomposiello, SI ;
Carretero, OA .
HYPERTENSION, 1997, 29 (01) :483-487
[3]   Inhibition of 20-HETE production contributes to the vascular responses to nitric oxide [J].
AlonsoGalicia, M ;
Drummond, HA ;
Reddy, KK ;
Falck, JR ;
Roman, RJ .
HYPERTENSION, 1997, 29 (01) :320-325
[4]   HYPERTENSION IN DAHL SALT-SENSITIVE RATS - BIOCHEMICAL AND IMMUNOHISTOCHEMICAL STUDIES [J].
BOUHNIK, J ;
RICHOUX, JP ;
HUANG, H ;
SAVOIE, F ;
BAUSSANT, T ;
ALHENOGELAS, F ;
CORVOL, P .
CLINICAL SCIENCE, 1992, 83 (01) :13-22
[5]   Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats [J].
Chao, J ;
Zhang, JJ ;
Lin, KF ;
Chao, L .
HUMAN GENE THERAPY, 1998, 9 (01) :21-31
[6]   L-ARGININE ABROGATES SALT-SENSITIVE HYPERTENSION IN DAHL RAPP RATS [J].
CHEN, PY ;
SANDERS, PW .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1559-1567
[7]   LOCUS FOR THE INDUCIBLE, BUT NOT A CONSTITUTIVE, NITRIC-OXIDE SYNTHASE COSEGREGATES WITH BLOOD-PRESSURE IN THE DAHL SALT-SENSITIVE RAT [J].
DENG, AY ;
RAPP, JP .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (05) :2170-2177
[8]   URINARY KALLIKREIN AND SALT SENSITIVITY IN ESSENTIAL HYPERTENSIVE MALES [J].
FERRI, C ;
BELLINI, C ;
CARLOMAGNO, A ;
PERRONE, A ;
SANTUCCI, A .
KIDNEY INTERNATIONAL, 1994, 46 (03) :780-788
[9]   Nitric oxide synthase activity and renal injury in genetic hypertension [J].
Hayakawa, H ;
Raij, L .
HYPERTENSION, 1998, 31 (01) :266-270
[10]   NITRIC-OXIDE SYNTHASE ISOFORM ACTIVITIES IN KIDNEY OF DAHL SALT-SENSITIVE RATS [J].
IKEDA, Y ;
SAITO, K ;
KIM, JI ;
YOKOYAMA, M .
HYPERTENSION, 1995, 26 (06) :1030-1034